SEC Form 4 · accession 0001144204-16-112017
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael M Goldberg
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 7, 2016 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 6, 2016 | A | 43,580 | $0.50 | A | 403,152 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from Issuer in lieu of cash compensation for board services during the second quarter of 2016.